© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
New Orleans - Following treatment with IV- or IM-administered alefacept (Amevive), more than 1,000 patients with chronic plaque psoriasis showed insignificant levels of drug-related antibody.